Page last updated: 2024-08-22

indocyanine green and Acute Relapsing Multiple Sclerosis

indocyanine green has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Albanese, M; Barbano, L; De Geronimo, D; Giorno, P; Landi, D; Marfia, GA; Parisi, V; Parravano, M; Ziccardi, L	1

Other Studies

1 other study(ies) available for indocyanine green and Acute Relapsing Multiple Sclerosis

Article	Year
Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2021, 03-01, Volume: 41, Issue:1 Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Indocyanine Green; Male; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Tomography, Optical Coherence; Visual Acuity	2021

Article

Year

Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2021, 03-01, Volume: 41, Issue:1

Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Indocyanine Green; Male; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Tomography, Optical Coherence; Visual Acuity

2021